Vimarsana
Biggest News Aggregation in the World

Takingg Oxycontin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Takingg Oxycontin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Takingg Oxycontin Today - Breaking & Trending Today

FOXNEWS Tucker Carlson Tonight December 6, 2019 05:47:00 - Vimarsana News

FOXNEWS Tucker Carlson Tonight December 6, 2019 05:47:00

About how the propaganda machine works in modern america. having made billions destroying an entire generation, purdue pharma used some of the profits to pay for publicity and did they get it. at some of the p.r. budget went to nonprofits in washington. according to reporting from propublica, from 2003 until recently, purdue pharma gave $50,000 a year to the american enterprise institute. it's a conservative think tank in washington, one of the richest. the money turned out to be very well spent. for about the price of a car, purdue pharma bought years of positive coverage from aei that helped...

FOXNEWS Tucker Carlson Tonight December 6, 2019 05:49:00 - Vimarsana News

FOXNEWS Tucker Carlson Tonight December 6, 2019 05:49:00

Abusers. the year that article appeared, 18,000 people died of opioid overdoses, the epidemic was raging out of control. according to the expert scholar, the real public health damage comes from the campaign by zealous prosecutors and advocates to demonize the drug itself. according to aei, the real crisis was not enough americans were takingg oxycontin. this was in effect ad copy, no different from a glossy insert counting the life enhancing benefits of consumer products, in one key way it was very different. if readers had no idea it was an ad for oxycontin. they assumed it was what it claim...

FOXNEWS Tucker Carlson Tonight December 6, 2019 05:48:00 - Vimarsana News

FOXNEWS Tucker Carlson Tonight December 6, 2019 05:48:00

For by purdue pharma researchers. the article didn't mention that fact. it also didn't mention the fact that the piece had been coordinated directly with the drug company. emails show aei scholar who piece sent a draft of the article to purdue pharma's chief lobbyist a month before the article came out seeking his approval and making certain it didn't seem to blatantly pro purdue. in 2007, that same scholar wrote an article for "the wall street journal" entitled "oxymoron," the piece chastised purdue for overprescribing its drugs but then it prescribed oxycontin as a godsend and worried physic...